. 2018 Jun 19;9(47):28691–28701. doi: 10.18632/oncotarget.25611

Table 3. Summary of cases with discordant data between immunohistochemistry and molecular MSI analysis.

Sample ID	IHC status	MLH1	MSH2	MSH6	PMS2	Molecular MSI status	HSP110 (T17) status
11.0011	negative	+	+	+	-	MSS	altered^a
12.0767	negative	-	+	+	-	MSS	altered^a
11.0226	negative	+	+	-	+	MSI-L	altered^a
13.0395	negative	+	+	+	-	MSI-L	altered^a
11.0404	positive	+	+	+	+	MSI-H	altered
11.0827	positive	+	+	+	+	MSI-H	altered
13.0578	positive	+	+	+	+	MSI-H	altered
13.1023	positive	+	+	+	+	MSI-H	altered

HSP110 (T17) status obtained by comparison between normal and tumor tissue DNA from the samples and also by R method.

+: positive protein expression; -: negative protein expression; MSS: microsatellite stability; MSI-L: low-microsatellite instability; MSI-H: high-microsatellite instability; ^a: analyzed by R method.